Patricia Winokur, MD
Executive Dean, University of Iowa Roy J. and Lucille A. Carver College of Medicine
Patricia Winokur, MD, was appointed executive dean of the UI Carver College of Medicine in 2016. In collaboration with the vice president for medical affairs/dean, she oversees activities for the academic component for the college, including the professional, graduate, and undergraduate education programs; research investments and programs; and collegiate space and faculty affairs.
Winokur is a nationally recognized researcher on the molecular mechanisms of antibiotic resistance, and she leads an active clinical research program focused on vaccine development and infectious disease diagnostics and treatments. She is co-principal investigator for the university’s National Institutes of Health (NIH)-sponsored Clinical and Translational Science Award (CTSA) and co-director of the UI Institute for Clinical and Translational Science (ICTS) that organizes much of the infrastructure for clinical and translational research at Iowa.
As the coronavirus pandemic became a rallying point for the university, Winokur helped lead the effort to enroll participants in studies of vaccines developed for COVID-19. She also was instrumental in working with various media outlets to help shape public understanding of the coronavirus and highlight the university’s role in the state’s public health efforts. Winokur also has led H1N1 influenza and various avian influenza vaccine trials that have been used to create national vaccine strategies for influenza pandemics.
Winokur serves on the editorial board of the Journal of Clinical Microbiology and is an ad hoc reviewer for Emerging Infectious Diseases, Antimicrobial Agents and Chemotherapy, and the New England Journal of Medicine.
A UI faculty member since 1993, Winokur received a Doctor of Medicine degree from the Washington University School of Medicine. She completed residency training in internal medicine and a fellowship in infectious diseases at Iowa, followed by a postdoctoral fellowship in tumor virus biology at the National Cancer Institute, part of the NIH.